The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?
anti-GluR delta antibody
anti-VGCC antibody
anti-mGluR antibody
cerebellar ataxias
immune-mediated cerebellar ataxias
long-term depression
prodromal phase
spinocerebellar ataxia
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
24 Feb 2022
24 Feb 2022
Historique:
received:
09
02
2022
revised:
21
02
2022
accepted:
21
02
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Long-term depression at parallel fibers-Purkinje cells (PF-PC LTD) is essential for cerebellar motor learning and motor control. Recent progress in ataxiology has identified dysregulation of PF-PC LTD in the pathophysiology of certain types of immune-mediated cerebellar ataxias (IMCAs). Auto-antibodies towards voltage-gated Ca channel (VGCC), metabotropic glutamate receptor type 1 (mGluR1), and glutamate receptor delta (GluR delta) induce dysfunction of PF-PC LTD, resulting in the development of cerebellar ataxias (CAs). These disorders show a good response to immunotherapies in non-paraneoplastic conditions but are sometimes followed by cell death in paraneoplastic conditions. On the other hand, in some types of spinocerebellar ataxia (SCA), dysfunction in PF-PC LTD, and impairments of PF-PC LTD-related adaptive behaviors (including vestibulo-ocular reflex (VOR) and prism adaptation) appear during the prodromal stage, well before the manifestations of obvious CAs and cerebellar atrophy. Based on these findings and taking into account the findings of animal studies, we re-assessed the clinical concept of LTDpathy. LTDpathy can be defined as a clinical spectrum comprising etiologies associated with a functional disturbance of PF-PC LTD with concomitant impairment of related adaptative behaviors, including VOR, blink reflex, and prism adaptation. In IMCAs or degenerative CAs characterized by persistent impairment of a wide range of molecular mechanisms, these disorders are initially functional and are followed subsequently by degenerative cell processes. In such cases, adaptive disorders associated with PF-PC LTD manifest clinically with subtle symptoms and can be prodromal. Our hypothesis underlines for the first time a potential role of LTD dysfunction in the pathogenesis of the prodromal symptoms of CAs. This hypothesis opens perspectives to block the course of CAs at a very early stage.
Identifiants
pubmed: 35326260
pii: brainsci12030303
doi: 10.3390/brainsci12030303
pmc: PMC8946597
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cerebellum. 2012 Sep;11(3):630-9
pubmed: 20480274
J Neurosci. 2016 May 4;36(18):4910-6
pubmed: 27147646
Mol Biomed. 2021 Jan 10;2(1):2
pubmed: 35006439
Mov Disord. 2021 Feb;36(2):471-480
pubmed: 33107647
J Neurosci. 2004 Oct 6;24(40):8853-61
pubmed: 15470152
Cerebellum. 2020 Dec;19(6):833-868
pubmed: 32632709
Front Neurol. 2017 Sep 11;8:472
pubmed: 28955296
Cerebellum. 2014 Apr;13(2):269-302
pubmed: 24307138
Mov Disord. 2014 Feb;29(2):252-5
pubmed: 24301795
Int J Mol Sci. 2020 Jul 13;21(14):
pubmed: 32668612
Prog Brain Res. 2014;210:59-77
pubmed: 24916289
Cell. 2006 Nov 17;127(4):697-708
pubmed: 17110330
J Physiol. 1982 Mar;324:113-34
pubmed: 7097592
J Physiol. 2017 Jan 1;595(1):141-164
pubmed: 27440721
Ann Neurol. 2003 Mar;53(3):325-36
pubmed: 12601700
Hum Mol Genet. 2004 Oct 15;13(20):2535-43
pubmed: 15317756
Handb Clin Neurol. 2012;103:461-73
pubmed: 21827907
Cerebellum. 2021 Dec;20(6):948-951
pubmed: 33754326
Cerebellum. 2022 Jan 22;:
pubmed: 35064896
Cerebellum. 2020 Feb;19(1):131-153
pubmed: 31879843
J Physiol. 1987 Dec;394:463-80
pubmed: 2832595
Cerebellum. 2022 Jan 12;:
pubmed: 35020135
Front Synaptic Neurosci. 2016 Nov 03;8:35
pubmed: 27857688
Mol Brain. 2013 Nov 19;6:48
pubmed: 24252411
Nat Neurosci. 2021 Feb;24(2):160-167
pubmed: 33288911
Brain Res. 2014 Oct 2;1583:220-9
pubmed: 25139423
Int J Environ Res Public Health. 2021 Sep 24;18(19):
pubmed: 34639359
Front Neurol. 2019 Nov 14;10:1183
pubmed: 31803128
J Neurosci. 2015 Jun 10;35(23):8882-95
pubmed: 26063920
Cerebellum. 2018 Dec;17(6):735-746
pubmed: 29982917
Nat Neurosci. 2000 Feb;3(2):157-63
pubmed: 10649571
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7428-7433
pubmed: 29941578
Arch Neurol. 2008 Apr;65(4):530-6
pubmed: 18413478
Nat Rev Neurosci. 2012 Sep;13(9):619-35
pubmed: 22895474
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1945-9
pubmed: 2419913
Physiol Rev. 2001 Jul;81(3):1143-95
pubmed: 11427694
F1000Res. 2017 Apr 4;6:416
pubmed: 28435670
Exp Brain Res. 2019 Feb;237(2):427-433
pubmed: 30430184
Dev Med Child Neurol. 2016 Jun;58(6):639-44
pubmed: 26814174
Mov Disord. 2021 Apr;36(4):985-994
pubmed: 33438269
PLoS One. 2015 Mar 18;10(3):e0119376
pubmed: 25785588
Neurobiol Dis. 2008 Jul;31(1):89-101
pubmed: 18502140
Int J Mol Sci. 2019 Dec 27;21(1):
pubmed: 31892274
Nat Neurosci. 2003 Aug;6(8):869-76
pubmed: 12833050